Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 14-Sep-23 9:17 PM View:  | Ikena Oncology, Inc. (IKNA) | 04-Aug-23 | Grant | 153,121 | -- | -- | 2% 7.78M to 7.93M | |
| 15-Jun-23 6:07 PM View: | Acutus Medical, Inc. (AFIB) | 15-Jun-23 | Grant | 8,400 | -- | -- | 68% 12.42K to 20.82K | |
| 24-May-23 5:07 PM View: | Prelude Therapeutics Inc (PRLD) | 22-May-23 | Private Purchase | 869,565 | $5.75 | $5,000,000.00 | 9% 9.78M to 10.65M | |
| 25-Nov-22 8:08 PM View: | Tricida, Inc. (TCDA) | 25-Nov-22 | Sale | 3,629,230 | $0.22 | $798,430.00 | (100%) 3.63M to 0 | |
| 25-Nov-22 8:08 PM View: | Tricida, Inc. (TCDA) | 23-Nov-22 | Sale | 5,617,300 | $0.21 | $1,179,630.00 | (61%) 9.25M to 3.63M | |
| 25-Nov-22 8:08 PM View: | Tricida, Inc. (TCDA) | 22-Nov-22 | Sale | 1,034,420 | $0.22 | $227,573.00 | (10%) 10.28M to 9.25M | |
| 21-Sep-22 5:59 PM View: | Third Harmonic Bio, Inc. (THRD) | 19-Sep-22 | Conversion | 5,479,070 | -- | -- | 100% 0 to 5.48M | |
| 21-Sep-22 5:59 PM View: | Third Harmonic Bio, Inc. (THRD) | 19-Sep-22 | Market Purchase Duplicate | 300,000 | $17.00 | $5,100,000.00 | 5% 5.48M to 5.78M | |
| 24-Jun-22 5:32 PM View: | Ikena Oncology, Inc. (IKNA) | 24-Jun-22 | Purchase | 162,000 | $4.96 | $803,975.00 | (2%) 7.94M to 7.78M | |
| 24-Jun-22 5:32 PM View: | Ikena Oncology, Inc. (IKNA) | 23-Jun-22 | Purchase | 23,419 | $3.71 | $86,884.50 | (< 1%) 7.64M to 7.61M | |
| 24-Jun-22 5:32 PM View: | Ikena Oncology, Inc. (IKNA) | 22-Jun-22 | Purchase | 66,806 | $3.55 | $237,161.00 | (< 1%) 7.66M to 7.59M | |
| 21-Jun-22 5:33 PM View: | Acutus Medical, Inc. (AFIB) | 16-Jun-22 | Grant | 8,400 | -- | -- | < 1% 6.55M to 6.56M | |
| 17-Nov-21 4:26 PM View: | Tricida, Inc. (TCDA) | 15-Nov-21 | Grant Duplicate | 666,667 | $6.00 | $4,000,000.00 | 7% 9.64M to 10.31M | 33% |
| 08-Sep-21 6:29 PM View: | Repare Therapeutics Inc. (RPTX) | 07-Sep-21 | Market Sale (Planned) Duplicate | 887 | $33.93 | $30,095.90 | (< 1%) 3.27M to 3.27M | 8% |
| 08-Sep-21 6:29 PM View: | Repare Therapeutics Inc. (RPTX) | 03-Sep-21 | Market Sale (Planned) Duplicate | 7,197 | $34.00 | $244,698.00 | (< 1%) 3.28M to 3.27M | 8% |
| 02-Sep-21 8:20 PM View: | Repare Therapeutics Inc. (RPTX) | 02-Sep-21 | Market Sale (Planned) | 16,424 | $34.24 | $562,358.00 | (< 1%) 3.3M to 3.28M | < 1% |
| 02-Sep-21 8:20 PM View: | Repare Therapeutics Inc. (RPTX) | 01-Sep-21 | Market Sale (Planned) | 12,968 | $33.98 | $440,653.00 | (< 1%) 3.31M to 3.3M | < 1% |
| 02-Sep-21 8:20 PM View: | Repare Therapeutics Inc. (RPTX) | 31-Aug-21 | Market Sale (Planned) | 8,472 | $33.94 | $287,540.00 | (< 1%) 3.32M to 3.31M | (< 1%) |
| 30-Aug-21 6:33 PM View: | Repare Therapeutics Inc. (RPTX) | 30-Aug-21 | Market Sale (Planned) | 6,697 | $33.92 | $227,162.00 | (< 1%) 3.33M to 3.32M | < 1% |
| 30-Aug-21 6:33 PM View: | Repare Therapeutics Inc. (RPTX) | 27-Aug-21 | Market Sale (Planned) | 7,093 | $33.94 | $240,736.00 | (< 1%) 3.33M to 3.33M | < 1% |
| 30-Aug-21 6:33 PM View: | Repare Therapeutics Inc. (RPTX) | 26-Aug-21 | Market Sale (Planned) | 4,283 | $34.52 | $147,849.00 | (< 1%) 3.34M to 3.33M | 2% |
| 25-Aug-21 8:36 PM View: | Repare Therapeutics Inc. (RPTX) | 25-Aug-21 | Market Sale (Planned) | 7,082 | $34.34 | $243,196.00 | (< 1%) 3.34M to 3.34M | 1% |
| 25-Aug-21 8:36 PM View: | Repare Therapeutics Inc. (RPTX) | 24-Aug-21 | Market Sale (Planned) | 4,039 | $34.07 | $137,609.00 | (< 1%) 3.35M to 3.34M | < 1% |
| 25-Aug-21 8:36 PM View: | Repare Therapeutics Inc. (RPTX) | 23-Aug-21 | Market Sale (Planned) | 7,094 | $34.06 | $241,622.00 | (< 1%) 3.36M to 3.35M | < 1% |
| 19-Aug-21 8:49 PM View: | Repare Therapeutics Inc. (RPTX) | 18-Aug-21 | Market Sale (Planned) | 2,930 | $33.99 | $99,590.70 | (< 1%) 3.36M to 3.36M | 1% |
| 25-Aug-21 8:25 PM View: | Repare Therapeutics Inc. (RPTX) | 18-Aug-21 | Market Sale (Planned) Duplicate | 2,930 | $33.99 | $99,590.70 | (< 1%) 3.36M to 3.36M | < 1% |
| 19-Aug-21 8:49 PM View: | Repare Therapeutics Inc. (RPTX) | 17-Aug-21 | Market Sale (Planned) | 17,398 | $34.12 | $593,620.00 | (< 1%) 3.38M to 3.36M | 2% |
| 25-Aug-21 8:25 PM View: | Repare Therapeutics Inc. (RPTX) | 17-Aug-21 | Market Sale (Planned) Duplicate | 17,398 | $34.12 | $593,620.00 | (< 1%) 3.38M to 3.36M | < 1% |
| 21-Jul-21 5:24 PM View: | Acutus Medical, Inc. (AFIB) | 19-Jul-21 | Market Purchase Duplicate | 1,071,430 | $14.00 | $15,000,000.00 | 20% 5.48M to 6.55M | (4%) |
| 16-Jul-21 4:21 PM View: | Enliven Therapeutics, Inc. (ELVN) | 16-Jul-21 | Market Purchase Duplicate | 1,666,670 | $6.00 | $10,000,000.00 | 66% 2.53M to 4.2M | (7%) |
| 22-Jun-21 5:05 PM View: | Acutus Medical, Inc. (AFIB) | 17-Jun-21 | Grant | 1,800 | -- | -- | < 1% 5.48M to 5.48M | |
| 11-Jun-21 6:04 PM View: | Tricida, Inc. (TCDA) | 10-Jun-21 | Grant Duplicate | 16,403 | -- | -- | < 1% 9.63M to 9.64M | |
| 01-Apr-21 6:14 PM View: | Ikena Oncology, Inc. (IKNA) | 30-Mar-21 | Conversion Duplicate | 7,099,800 | -- | -- | 100% 0 to 7.1M | |
| 01-Apr-21 6:14 PM View: | Ikena Oncology, Inc. (IKNA) | 30-Mar-21 | Purchase Duplicate | 423,400 | $16.00 | $6,774,400.00 | 6% 7.1M to 7.52M | |
| 30-Sep-20 7:52 PM View: | Prelude Therapeutics Inc (PRLD) | 29-Sep-20 | Conversion Duplicate | 8,332,780 | -- | -- | 577% 1.44M to 9.78M | |
| 30-Sep-20 7:52 PM View: | Prelude Therapeutics Inc (PRLD) | 25-Sep-20 | Purchase Duplicate | 1,236,800 | $19.00 | $23,499,200.00 | 598% 206.91K to 1.44M | |
| 12-Aug-20 9:06 PM View: | Acutus Medical, Inc. (AFIB) | 10-Aug-20 | Conversion Duplicate | 5,062,960 | -- | -- | 227856% 2.22K to 5.07M | |
| 12-Aug-20 9:06 PM View: | Acutus Medical, Inc. (AFIB) | 10-Aug-20 | Purchase Duplicate | 415,000 | $18.00 | $7,470,000.00 | 8% 5.07M to 5.48M | |
| 07-Aug-20 8:00 PM View: | Acutus Medical, Inc. (AFIB) | 05-Aug-20 | Grant | 2,222 | -- | -- | 100% 0 to 2.22K | |
| 25-Jun-20 5:54 PM View: | Repare Therapeutics Inc. (RPTX) | 23-Jun-20 | Conversion Duplicate | 2,601,320 | -- | -- | 100% 0 to 2.6M | |
| 25-Jun-20 5:54 PM View: | Repare Therapeutics Inc. (RPTX) | 23-Jun-20 | Purchase Duplicate | 774,200 | $20.00 | $15,484,000.00 | 30% 2.6M to 3.38M | |
| 15-Jun-20 7:50 PM View: | Tricida, Inc. (TCDA) | 11-Jun-20 | Grant Duplicate | 5,670 | -- | -- | < 1% 9.62M to 9.63M | |
| 16-Mar-20 5:17 PM View: | Enliven Therapeutics, Inc. (ELVN) | 16-Mar-20 | Conversion Duplicate | 1,594,900 | -- | -- | 170% 937.5K to 2.53M | |
| 16-Mar-20 5:17 PM View: | Enliven Therapeutics, Inc. (ELVN) | 12-Mar-20 | Purchase Duplicate | 937,500 | $16.00 | $15,000,000.00 | 100% 0 to 937.5K | |
| 12-Dec-19 5:23 PM View: | Tricida, Inc. (TCDA) | 11-Dec-19 | Market Sale Duplicate | 1,500,000 | $40.00 | $60,000,000.00 | (13%) 11.12M to 9.62M | 81% |
| 04-Jun-19 8:27 PM View: | Tricida, Inc. (TCDA) | 31-May-19 | Grant | 1,879 | -- | -- | < 1% 11.12M to 11.12M | |
| 05-Apr-19 3:26 PM View: | Tricida, Inc. (TCDA) | 03-Apr-19 | Market Purchase Duplicate | 225,000 | $36.00 | $8,100,000.00 | 2% 10.89M to 11.11M | (79%) |
| 19-Oct-18 4:50 PM View: | Si-Bone, Inc. (SIBN) | 19-Oct-18 | Conversion | 785,368 | -- | -- | 100% 0 to 785.37K | |
| 19-Oct-18 4:50 PM View: | Si-Bone, Inc. (SIBN) | 19-Oct-18 | Purchase | 200,000 | $15.00 | $3,000,000.00 | 25% 785.37K to 985.37K | |
| 02-Jul-18 9:08 PM View: | Tricida, Inc. (TCDA) | 02-Jul-18 | Grant | 3,632 | -- | -- | 100% 0 to 3.63K |